Scholarly publications and presentations by Rochester Regional Health's Allergy and Immunology department authors.

Follow


Submissions from 2025

Link

2-1-2025          Characterization of Real World Food Allergy Management Choices, Allison Ramsey, Rochester Regional Health, Peter Capucilli, Rochester Regional Health, Sara Patrawala, Rochester Regional Health, et al.

Link

2-1-2025          Enhancing Peanut and Tree Nut Allergy Diagnostics Using Linear and Conformational IgE Epitopes of Vicilin-Buried Peptides, Lauren Swientoniewski, Ian Rambo, Jacqueline Nesbit, et al.

Link

2-1-2025          Health-related quality of life and treatment satisfaction in pediatric patients with hypogammaglobulinemia treated with subcutaneous versus intravenous immunoglobulin replacement therapy, Kevin Ackerman, Peter Capucilli, Rochester Regional Health, Jennifer Heimall, et al.

Link

2-1-2025          Higher Prevalence of Humoral Immunodeficiency in Patients with Severe COPD, Ruth Agwaze; Allison Ramsey, Rochester Regional Health; and S Shahzad Mustafa, Rochester Regional Health

Link

2-1-2025          Obstetric penicillin allergy evaluations, Lakshmi G. Nair; S Shahzad Mustafa, Rochester Regional Health; and Allison Ramsey, Rochester Regional Health

Link

2-1-2025          Safety and Efficacy of Outpatient Drug Challenges, Unaiza Faizan, Rochester Regional Health, Shiamak Cooper, Rochester Regional Health, Alshaima Yousef, Rochester Regional Health, et al.

Link

2-1-2025          Steroid stewardship in allergy/immunology: An opportunity for improved clinical outcomes, Sara Patrawala, Rochester Regional Health; Allison Ramsey, Rochester Regional Health; and S Shahzad Mustafa, Rochester Regional Health

Link

2-1-2025          The Safety And Efficacy Of Dupilumab In A Real-World Clinical Setting: The RAPID Asthma Prospective Registry, Anju Peters, Ole Hilberg, Njira Lugogo, et al.

Link

1-29-2025          Hypersensitivity Reactions to Anticonvulsants, Unaiza Faizan, Rochester Regional Health and Allison Ramsey, Rochester Regional Health

Link

1-1-2025          Development and acceptability of a decision-aid for food allergy oral immunotherapy in children, Aikaterini Anagnostou, Elissa M. Abrams, Melanie Carver, et al.

Submissions from 2024

Link

12-1-2024          AAAAI Position Statement on Changing Electronic Health Record Allergy Documentation to "Alerts" to Lead to Easily Understood, Actionable Labels, Andrew A. White, Scripps Clinic, La Jolla, Calif., Allison Ramsey, Rochester Regional Health, Autumn Guyer, Memorial Sloan Kettering Cancer Center, New York, NY., et al.

Link

12-1-2024          Improving Adherence in Allergy Care: Challenges and Solutions, Allison C. Ramsey, Rochester Regional Health and Jay M. Portnoy, Division of Allergy, Immunology, Pulmonary and Sleep Medicine. Children's Mercy Hospital, Kansas City, Mo.

Link

11-1-2024          Role of an embedded health system specialty pharmacy on prescription of biologics in allergy/immunology, Sara Patrawala, Rochester Regional Health; S Shahzad Mustafa, Rochester Regional Health; and Allison Ramsey, Rochester Regional Health

File

10-17-2024          Management of Asthma (and More) with Biologics, S Shahzad Mustafa, Rochester Regional Health

Link

10-1-2024          Dupilumab efficacy across serum IgE and blood eosinophil levels in chronic rhinosinusitis with nasal polyposis, Claus Bachert, University Hospital of Münster, Münster, Germany., Philippe Gevaert, Ghent University, Ghent, Belgium., Brian Lipworth, University of Dundee, Dundee, UK., et al.

Link

10-1-2024          Transitions of Care in Patients With Inborn Errors of Immunity, Benjamin T. Prince, Division of Allergy and Immunology, Nationwide Children's Hospital, Columbus, Ohio., Amy Garee, Division of Allergy and Immunology, Nationwide Children's Hospital, Columbus, Ohio., Anne Marie Holly, Rochester Regional Health, et al.

Link

9-1-2024          A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology, Jay A. Lieberman, Department of Pediatrics, The University of Tennessee Health Science Center and LeBonheur Children's Hospital, Memphis, Tennessee., Derek K. Chu, Departments of Medicine and Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada; Evidence in Allergy Group, McMaster University and The Research Institute of St. Joe's Hamilton, Hamilton, Canada., Tasnuva Ahmed, Department of Health Research Methods, Evidence, and Impact, Evidence in Allergy Group, McMaster University, Hamilton, Canada., et al.

Link

9-1-2024          Does Comorbid Food Allergy Affect Response to Omalizumab in Patients with Asthma?, Alessandro Fiocchi, Bambino Gesù Childrens' Hospital IRCCS, Rome, Italy., R Sharon Chinthrajah, Stanford University, Stanford, CA, USA., Ignacio J. Ansotegui, Hospital Quironsalud Bizkaia, Bilbao, Spain., et al.

Link

8-1-2024          Infant anaphylaxis and epinephrine use: Can we improve acute management?, Aikaterini Anagnostou, Matthew Greenhawt, S Shahzad Mustafa, Rochester Regional Health, et al.

Link

8-1-2024          Omalizumab in food allergy: Risks and benefits, S Shahzad Mustafa, Rochester Regional Health and Kristin Sokol

Link

8-1-2024          Real-world adoption of peanut oral immunotherapy in infants and toddlers, S Shahzad Mustafa, Rochester Regional Health, Peter Capucilli, Rochester Regional Health, Linh-An Tuong, Rochester Regional Health, et al.

Link

8-1-2024          Secondary Immunodeficiency and Vaccine Response in Rheumatoid and Psoriatic Arthritis on Immunosuppressive Medicines, Anthony J. Ocon, Rochester Regional Health, Shiamak Cooper, Rochester Regional Health, Allison Ramsey, Rochester Regional Health, et al.

Link

6-1-2024          Patient partnerships and minimally disruptive medicine, S Shahzad Mustafa, Rochester Regional Health, Aikaterini Anagnostou, Division of Allergy and Immunology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas., Matthew Greenhawt, Section of Allergy and Clinical Immunology, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colorado., et al.

Link

6-1-2024          Unveiling a low-hanging fruit: Single-center study on secondary immunodeficiency in newly diagnosed chronic lymphocytic leukemia and multiple myeloma, Zeni Kharel, Rochester Regional Health, Himal Kharel, Rochester Regional Health, S. Shahzad Mustafa, Rochester Regional Health, et al.

Link

5-1-2024          Delabeling drug allergy on a college campus, Anna Wolfson, Harvard Medical School, Boston, Massachusetts; Massachusetts General Hospital, Boston, Massachusetts. and Allison Ramsey, Rochester Regional Health